Prospects for Clinical Introduction of Nitroimidazole Antibiotics for the Treatment of Tuberculosis

E-ISSN： 1873-4286|10|26|3239-3262

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.26, 2004-10, pp. : 3239-3262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tuberculosis: Current Treatment, Diagnostics, and Newer Antitubercular Agents in Clinical Trials

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 15, Iss. 1, 2015-03 ,pp. : 32-41

Bentham Science Publishers

Access to resources Recommend Favorite

Transdermal Delivery of Treatment for Alzheimer's Disease: Development, Clinical Performance and Future Prospects

By Chan Agnes L.F. Chien Yie W. Shun Jin Lin

Drugs & Aging, Vol. 25, Iss. 9, 2008-01 ,pp. : 761-775

Adis International

Access to resources Recommend Favorite

Fluoroquinolones: An Important Class of Antibiotics Against Tuberculosis

Current Medicinal Chemistry, Vol. 13, Iss. 4, 2006-02 ,pp. : 455-463

Bentham Science Publishers

Access to resources Recommend Favorite

Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment

By Engohang-Ndong Jean

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1789-1800

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for the treatment of tuberculosis

By Yew Wing Wai Cynamon Michael Zhang Ying

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 1, 2011-03 ,pp. : 1-21

Informa Healthcare

Access to resources Recommend Favorite